Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
US Market
Holding ITRM?
Track your performance easily

Iterum Therapeutics (ITRM) Income Statement

713 Followers

Iterum Therapeutics Income Statement

Last quarter (Q2 2024), Iterum Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Iterum Therapeutics's net income was $-5.00M. See Iterum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 37.00K
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 29.49M$ 47.47M$ 30.38M$ 24.54M$ 32.13M$ 102.06M
Operating Income
$ -29.49M$ -47.47M$ -30.38M$ -24.54M$ -32.13M$ -102.02M
Net Non Operating Interest Income Expense
$ -1.78M$ -1.43M$ -2.36M$ -5.55M$ -17.95M$ -861.00K
Other Income Expense
$ 2.25M$ -11.49M$ 11.74M$ 60.77M$ -1.19M$ 196.00K
Pretax Income
$ -33.84M$ -37.76M$ -44.13M$ -90.86M$ -51.26M$ -102.69M
Tax Provision
$ 389.00K$ 613.00K$ 301.00K$ 705.00K$ 743.00K$ 444.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -34.01M$ -38.37M$ -44.43M$ -91.56M$ -52.01M$ -103.13M
Basic EPS
$ -2.49$ -2.96$ -3.63-$ -2.17$ -7.10
Diluted EPS
$ -2.49$ -2.96$ -3.63$ -8.40$ -2.17$ -7.10
Basic Average Shares
$ 57.61M$ 12.96M$ 12.24M$ 10.89M$ 24.01M$ 14.52M
Diluted Average Shares
$ 57.61M$ 12.96M$ 12.24M$ 10.89M$ 24.01M$ 14.52M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----$ -1.40$ -7.10
Reported Normalized Diluted E P S
----$ -1.40$ -7.10
Rent Expense Supplemental
------
Total Expenses
$ 29.49M$ 47.47M$ 30.38M$ 24.54M$ 32.13M$ 102.06M
Net Income From Continuing And Discontinued Operation
$ -34.01M$ -38.37M$ -44.43M$ -91.56M$ -52.01M$ -103.13M
Normalized Income
$ -21.42M---$ -50.98M$ -103.13M
Interest Expense
----$ 15.10M$ 861.00K
EBIT
$ -33.84M$ -36.33M$ -42.12M$ -90.86M$ -36.17M$ -101.83M
EBITDA
$ -30.65M$ -34.58M$ -38.17M$ -84.02M$ -36.01M$ -101.67M
Currency in USD

Iterum Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis